Drawing on her extensive experience defending clients against health care fraud enforcement actions, Laura Laemmle-Weidenfeld also provides practical compliance advice on Medicare and Medicaid fraud and abuse issues. She has defended against numerous investigations and litigation brought by the Department of Justice (DOJ), various U.S. Attorneys offices, the Department of Health and Human Services Office of Inspector General (HHS-OIG), state attorneys general, and other state and federal agencies. Laura also helps her clients navigate challenging compliance issues, including analyzing arrangements under the Stark Laws and Antikickback Statute, conducting internal investigations, and preparing self-disclosures. She has represented a broad spectrum of health care providers, including hospitals and health systems, home health care agencies, telehealth providers, physician practices, clinical laboratories, post-acute care providers, and pharmacies, as well as pharmaceutical and medical device manufacturers.
Earlier in her career, Laura served as a trial attorney in the Frauds Section of the DOJ's Civil Division, where she conducted health care fraud investigations and litigation matters brought under the False Claims Act (FCA) and its whistleblower (or qui tam) provisions. While at the DOJ, she focused largely on FCA matters alleging violations of the Antikickback Statute; Stark Laws; and Federal Food, Drug, and Cosmetic Act.
An active member of the American Health Lawyers Association (chair, Fraud and Abuse Practice Group, 2014-2017), American Bar Association, BNA's Medical Devices Law & Industry Report advisory board, and Law360's health editorial advisory board, Laura frequently speaks and writes on health care fraud issues.
Laura received her J.D. from Georgetown University Law Center and her undergraduate degrees from Northwestern University.